Nizoral - why does it work? Androgens, fungi, inflammation.

harold

Established Member
Reaction score
11
OK wanted to ask a question and again talk about inflammation maybe.
We all know that Nizoral/ketoconazole has some positive effects on hair. But we are not sure exactly why. it seems to be for a host of possible reasons - ketoconazole has been shown to reduce the activity of the androgen receptor/ DHT complex, it has been shown to enhance the growth of hair in mice, it is an antifungal (and also has anti-inflammatory and anti-bacterial properties), and it can interfere with steroid synthesis a lot earlier than the testosterone to dihydrotestosterone step. Which of these is important in giing it the effect of increasing hair density, diameter and reducing sebum output. It would seem obvious that it is the antiandrogenic properties that have this effect and the fact that it is also antifungal is purely coincidental.

However it is odd to consider that an unrelated antifungal - piroctine olamine performed at least as well as ketoconazole in terms of increasing hair density, diameter and reducing sebum output. Even "ordinary" antidandruff ingredient zinc pyrithione increased hair density though it did not help diamter or sebum output. It would seem to be something of a coincidence that PO is also antiandrogenic. Perhaps the fact that all these antifungal shampoos help to one extent or another is due to something else. A positive correlation has been found between telogen hair counts and dandruff severity in men suffering recurrent dandruff. People whose hair tested positive for the presence of Malassezia fungi was found far more often amongst "subjects with hair shedding than among normal subjects (89.92% vs 9.52%, p<0.001). Furthermore, participants with positive smears had a significantly higher frequency of hair loss complaints and positive hair-pull tests."
Amongst Korean adolescents suffering from androgenetic alopecia the disease most associated was sebborheic dermatitis, followed by acne and finally atopic dermatitis. Interesting that acne, considered the closest relative of Androgenetic Alopecia in the sense of its androgen dependece, was beaten out by seb derm and that atopic dermatitis - an inflammatory skin disease (with links to the same/similar type of fungus) came in next. The presence of Malassezia fungi has been shown to induce/alter cytokine production withim keratinocytes including our old friend TGF-Beta "Moreover, we demonstrated that M. furfur modulates proinflammatory and immunomodulatory cytokine synthesis by downregulating IL-1alpha and by inhibiting IL-6 and TNF-alpha and by upregulating IL-10 and TGF-beta1."

I find this....interesting. Its a whole bunch of circumstantial evidence but some of it at least seems to indicate that fungal infection/inflammatory aspects are very important. The fact that all antifungals - not just ketocconazzole - seem to help is the most difficult factor to explain.

If I were to take a shot - I would say that androgens lead to loss of immune privilege in vulnerable hair follicles as shown in the Cotsarelis patent and also sebaceous gland enlargement. An increased presence of lipophillic yeast triggers an immune response centred around the upper portions of the hair follicle as seen in pretty much all immunohistochemical investigations of male pattern baldness scalp. This being close to the "bulge" region of the follicle wherein the stem cell population that gives rise to future hair cycles lies - this is eventually caught in the crossfire, and, lacking sufficient markers to tell the immune system to "back off" is gradually destroyed.

I found this today from the 2005 article "Dermocosmetic Aspects of Hair and Scalp" by Trueb which had quite a few of these ideas.
"Clinical Approach to Common Hair and Scalp Complaints

Antonella Tosti reviewed conditions underlying common hair and scalp complaints, such as hair weathering, dandruff, itchy scalp, greasy scalp, and the "red scalp syndrome," and further characterized them on the basis of videodermoscopy findings. Epiluminiscence microscopy of the scalp at times 10 magnification reveals pathologic conditions of the hair shaft and scalp not readily recognized by the naked eye. Examples are hair diameter diversity, the "peripilar signs" (PPS) around the hair ostia and vascular abnormalities (teleangiectasia) of the scalp.

Hair diameter diversity has been identified as a marker for the hair follicle miniaturization process in the course of androgenetic alopecia (de Lacharrière et al, 2001).

A correlation of PSS with histological findings has revealed that the presence of PPS could reflect the presence of perifollicular inflammatory infiltrates and fibrosis (Deloche et al, 2004). The implication of microscopic follicular inflammation in the pathogenesis of androgenetic alopeica (Androgenetic Alopecia) has emerged from several independent studies (Jaworsky et al, 1992;Whiting, 1993;Mahéet al, 2000). The term "microinflammation" has been proposed, because the process involves a slow, subtle, and indolent course, in contrast to the inflammatory and destructive process in the classical inflammatory scarring alopecias (Mahéet al, 2000). An important question is how the inflammatory reaction pattern is generated around the individual hair follicle. The localization in the upper follicle near the infundibulum suggests that the primary causal event for the triggering of inflammation might occur at this site. Considering the microbial colonization of the follicular infundibulum, one could speculate that microbial toxins or antigens may be involved in the generation of the inflammatory response. Alternatively, keratinocytes themselves may respond to chemical stress from irritants, pollutants, and ultraviolet (UV) irradiation, by producing radical oxygen species, nitric oxide, and releasing pro-inflammatory cytokines. In the case where the causal agents persist, sustained inflammation occurs, together with connective tissue remodeling, where collagenases play a role. Collagenases are suspected to contribute to the tissue changes in perifollicular fibrosis. Finally, permanent hair loss results form irreversible damage to the putative site of follicular stem cells in the "bulge" area of the outer-root sheath in the superficial portion of the hair follicle (Lavker et al, 1993). The preference of this site for the immunologic attack may be related to the fact that, in contrast to the proximal hair follicle, the isthmus, and infundibulum area do not bear any immune privilege (Paus, 1997).

The "red scalp syndrome" is an ill-defined condition, characterized by persistent erythema of the scalp that is not otherwise explained through a specific dermatologic condition, such as seborrhoic dermatitis. First described byThestrup-Pedersen and Hjorth (1987), it has been commented upon in the English language byMoschella (1994), who stated the problem of "diffuse red scalp disease which can also be itchy and burning. Clinically, there is no scaling, no hair loss, and no scarring. It is non responsive to any therapy including potent topical steroids or anti-seborrhoic therapy." A study of 18 patients with "red scalp syndrome" showed that the scalp redness was associated with Androgenetic Alopecia in the majority of patients.1 Patients often report associated discomfort of the scalp (trichodynia). In another series of patients complaining of hair loss and trichodynia, the dermatoscopic finding of scalp telangiectasia was found to strongly correlate with the presence of trichodynia (Willimann and Trüeb, 2002). An interesting analogy to rosacea exists, in which it was found that patients with the telangiectatic variant respond more frequently with astinging sensation to the topical application of 5% lactic acid on the cheek than patients with the papulopustular type of rosacea or normal controls (Lonne-Rahm et al, 1999). In patients with trichodynia, overexpression of neuropeptide substance P has been found (Ericson et al, 1999), suggesting a connection between sensory or subjective irritation and cutaneous vascular reactivity."

Quick glossary - "trichodynia" basically means scalp pain and "telangiectasia" azre small dilated blood vessels close to the skin surface, the sort responsible for "port wine stain" birthmarks.

Substance P mediates stress related hair loss - "Organ-cultured HFs responded to substance P by premature catagen development, down-regulation of NK1, and up-regulation of neutral endopeptidase (degrades substance P). This was accompanied by mast cell degranulation in the HF connective tissue sheath, indicating neurogenic inflammation. Substance P down-regulated immunoreactivity for the growth-promoting NGF receptor (TrkA), whereas it up-regulated NGF and its apoptosis- and catagen-promoting receptor (p75NTR). In addition, MHC class I and beta2-microglobulin immunoreactivity were up-regulated and detected ectopically, indicating collapse of the HF immune privilege." Possibly it plays a role in male pattern baldness as well as it seems to be implicated in the red/painful/itchy nature of Androgenetic Alopecia scalp.

Thoughts people?
hh
 

michael barry

Senior Member
Reaction score
14
I washed a wrist in Nizoral for three months way on back, and to my suprise it actually made the hair thicker there. It got longer and darker also.

Both nizoral and piroctone olamine also decreased sebum secretions and I know that nizoral actually shrank sebaceous glands by almost 20%.


So on one hand its anit-androgenic (if you leave it in long enogh to penetrate) and on the other its a hypertrichotic (was on my arm hair). It was about as effective as 1% minoxidil in six month tests. minoxidil grows more hair for a while (less than 2 years anyway) than finasteride does---------thats something to keep in mind.


Nizoral also inteferes with two or three prostaglandins..................something else to keep in mind.
 

harold

Established Member
Reaction score
11
" Inflammation is rather like a bomb in that stuff around the target takes a hit too.The inflammation is around the sebaceous gland which just happens to be very close to the bulge area where hair follicle stem cells are produced.So if the stem cells are getting hit with inflammatory cytokines then we have no replacement cells for hair follicle renewal."

That quote from kingpin from that thread is pretty much what I think might be happening.
hh
 

michael barry

Senior Member
Reaction score
14
Harold,

Armando thought much the same thing............................about sebum getting backed up there.



NOTE------------Salycic acid is one hell of an anti-inflammatory. T-SAL has never been tested for Androgenic Alopecia though.................might be interesting to try.




SECOND NOTE: Ive suggested as much about DKK-1. DKK-1 kills keratinocyte cells, so you have dead keratinocyte cells flowing out of the body riding the hair up near an area with no immunological priveledges (the infidulum). The immune system might be attacking the dead cells there.



It would be interesting to see what an anti-DKK1 substance could do in Androgenetic Alopecia.



Harold, as always, the lack of testing is infuriating. It would only take a couple of men and a doctor to try these things and see if there was any efficacy. However, head hair growth is slowed by androgens in test tubes also..................I keep that in mind. Its definitley not the mites that live off sebum, because nioxin had a product that dealt with that and it wasn't successful.
 

bornthisway

Established Member
Reaction score
9
harold said:
However it is odd to consider that an unrelated antifungal - piroctine olamine performed at least as well as ketoconazole in terms of increasing hair density, diameter and reducing sebum output. Even "ordinary" antidandruff ingredient zinc pyrithione increased hair density though it did not help diamter or sebum output. It would seem to be something of a coincidence that PO is also antiandrogenic. Perhaps the fact that all these antifungal shampoos help to one extent or another is due to something else. A positive correlation has been found between telogen hair counts and dandruff severity in men suffering recurrent dandruff. People whose hair tested positive for the presence of Malassezia fungi was found far more often amongst "subjects with hair shedding than among normal subjects (89.92% vs 9.52%, p<0.001). Furthermore, participants with positive smears had a significantly higher frequency of hair loss complaints and positive hair-pull tests."

hh

'Although the effects of Ketoconazole on 5 alpha - reductase had been documented earlier, the authors of the study asserted that androgenetic alopecia has a multi-factorial pathogenesis with an inflammatory reaction caused by a Malassezia fungal infection, and claimed that the Ketoconazole shampoo was probably effective due to its beneficial effect on fungal scalp infections in genetically predisposed individuals. It was concluded that Ketoconazole was therapeutic by reducing inflammation through its anti-inflammatory properties and by clearing the adjacent fungal infection.

Exploration of the inflammatory aspect of androgenetic alopecia was largely based on the results of a biopsy study by Jaworsky et al., showing that androgenetic alopecia patients had signs of T-cell infiltration of follicular stem cell epithelium. However, the veracity of the conclusions drawn from the Jaworsky study is uncertain as the study included 4 subjects and only 3 of them were men.'

Jaworsky study:

Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis:

Hair-bearing, transitional, and alopecic scalp from three males and one female with progressive pattern alopecia were examined. Ultrastructural studies disclosed measurable thickening of the follicular adventitial sheaths of transitional and alopecic zones compared with those in the non-alopecic zones. This finding was associated with mast cell degranulation and fibroblast activation within the fibrous sheaths. Immunohistochemically, control biopsies were devoid of follicular inflammation (n = 3), while transitional regions consistently showed the presence of activated T-cell infiltrates about the lower portions of follicular infundibula. These infiltrates were associated with the induction of class II antigens on the endothelial linings of venules within follicular adventitia and with apparent hyperplasia of follicular dendritic cells displaying the CD1 epitope. Inflammatory cells infiltrated the region of the follicular bulge, the putative source of stem cells in cycling follicles. The data suggest that progressive fibrosis of the perifollicular sheath occurs in lesions of pattern alopecia, and may begin with T-cell infiltration of follicular stem cell epithelium. Injury to follicular stem cell epithelium and/or thickening of adventitial sheaths may impair normal pilar cycling and result in hair loss.

PMID: 1390168

So, one school of thought believes the inflammatory reaction in androgenetic alopecia is caused by a Malassesia fungal infection.

Ciclopirox olamine (1.5%) appears slightly more effective than ketoconazole shampoo (2%) regarding itching and scaling.


CONCLUSIONS: CPO shampoo was superior to placebo and at least as effective as ketoconazole shampoo in treating scalp seborrhoeic dermatitis. Patients rated the overall improvement as better with CPO than with ketoconazole shampoo.

Lithium gluconate appears to be marginally more effective than ketoconazole with respect to treating seborrhoeic dermatitis.

Results The intent-to-treat analysis (ITT) involved 288 patients and the per protocol (PP) analysis 269 patients. Treatment groups were comparable at baseline on age, sex, disease duration and symptoms. For the main criterion, the success rate was 52·0% (lithium) vs. 30·1% (ketoconazole) in the ITT population and 53·2% (lithium) vs. 30·7% (ketoconazole) in the PP population. The non-inferiority of lithium was demonstrated with differences of 21·9% (95% CI 10·0–33·7%) and 22·5% (95% CI 10·2–34·8%), respectively, in the ITT and PP population. As the lower limit of the 95% CI was > 0, the superiority of lithium was shown. Lithium also showed better results on other symptoms: burning and dryness. Adverse events were reported by 26·3% (lithium) and 25% (ketoconazole) of patients.

Conclusions Lithium was 22% more effective than ketoconazole in giving complete remission of seborrhoeic dermatitis, with comparable safety.

Recent theory regarding efficacy of lithium gluconate has to do with anti-inflammatory effects on keratinocytes:

Topical lithium (Li) gluconate has a beneficial effect on seborrhoeic dermatitis (SD), unlike oral lithium (Li) used in psychiatry. SD is an inflammatory dermatitis associated, in most of cases, with colonization by lipophilic yeasts of the genus Malassezia. However, the exact mechanism of action of Li gluconate in SD still remains unknown. The aim of our study was to investigate the effect of topical Li on cytokine secretion and innate immunity. For this purpose, we investigated first the modulatory effect of Li on two pro-inflammatory and two anti-inflammatory cytokine secretion and second, the modulatory effect of Li on Toll-like receptor (TLR) 2 and 4 expression by unstimulated and stimulated keratinocytes. Two different skin models were used: keratinocytes in monolayer and skin explants. In some of them, inflammation was induced with LPS (1 mug/ml) or zymosan (2 mg/ml). Then the skin models were incubated with Li gluconate (Labcatal*, Montrouge, France) at three different concentrations (1.6, 3, 5 mM) determined according to viability MTT test. Expression of TNFalpha, IL6, IL10, TGFbeta1, TLR2 and TLR4 was detected by immunohistochemistry (IHC). Cytokines were quantified by ELISA methods. Our results showed that the effect of Li on keratinocytes is dose-dependent. At low concentration (1.6 mM), Li enhanced TNFalpha secretion, whereas, at higher concentration (5 mM), Li significantly enhanced IL10 expression and secretion. However, there was no significant modulation of Li on IL6 and TGFbeta1 secretion. Moreover, Li at 5 mM significantly decreased TLR2 and TLR4 expressions by differentiated keratinocytes. As Li concentration during topical treatment is probably closer to 5 mM than to 1 mM, the therapeutic effect of Li gluconate in DS may be explained by two anti-inflammatory actions: an increased expression and secretion of IL10 and a decreased expression of TLR2 and TLR4 by keratinocytes. The diminution of TLR2 expression by Li may not allow MF to trigger inflammation response in lesional skin.

PMID: 18330588
 

michael barry

Senior Member
Reaction score
14
This is where I remind everyone that not every subject with androgenic alopecia is found to have inflammation. Some men bald with no inflammation at all.
 

treeshrew

Experienced Member
Reaction score
0
My personal experience with nizoral has been negative. And to be honest I'm not sure how it got "big 3" status.

Since starting propecia my hair has stopped shedding - I especially notice this in the shower. However, when I use nizoral I always get a nice clump of hair that comes out along with the goopy, white nizoral residue.

Unless you have a specific fungus, excessive dandruff, or some other scalp condition that is accelerating hairloss I would not recommend using Nizoral based on my own personal experiences.

To me the big guns are minoxidil and finasteride - everything else is flavoring.
 

bornthisway

Established Member
Reaction score
9
michael barry said:
This is where I remind everyone that not every subject with androgenic alopecia is found to have inflammation. Some men bald with no inflammation at all.

I wonder how their hair loss progresses compared to those with inflammation, and what treatments they are more or less responsive to. male pattern baldness is definitely multi-factorial so everyone won't respond to the same treatments.

michael barry said:
SECOND NOTE: Ive suggested as much about DKK-1. DKK-1 kills keratinocyte cells, so you have dead keratinocyte cells flowing out of the body riding the hair up near an area with no immunological priveledges (the infidulum). The immune system might be attacking the dead cells there.



It would be interesting to see what an anti-DKK1 substance could do in Androgenetic Alopecia.

Lithium and DMSO seems promising. There are claims of thickening/hair growth/inflammation supression.
 

harold

Established Member
Reaction score
11
bornthisway said:
michael barry said:
This is where I remind everyone that not every subject with androgenic alopecia is found to have inflammation. Some men bald with no inflammation at all.

I wonder how their hair loss progresses compared to those with inflammation, and what treatments they are more or less responsive to. male pattern baldness is definitely multi-factorial so everyone won't respond to the same treatments.

According to the one study those without inflammation (at least in which inflammation was not obvious enough to be detected - pretty sure they did not do a tissue biopsy) responded better to minoxidil than those with.
hh
 

harold

Established Member
Reaction score
11
treeshrew said:
My personal experience with nizoral has been negative. And to be honest I'm not sure how it got "big 3" status.

By having multiple studies/trials that show that it produces a positive effect in Androgenetic Alopecia.

Since starting propecia my hair has stopped shedding - I especially notice this in the shower. However, when I use nizoral I always get a nice clump of hair that comes out along with the goopy, white nizoral residue.

If nizoral was actually a negative it would not be causing hairs to jump off your head 5 minutes after you applied it to your scalp. Was your negative experience based on an increase in sheding during the time you were using it or just that you notice more hairs when you use it? I always have a LOT more hairs when I shower and shampoo as compared to when I just shower.
hh
 

harold

Established Member
Reaction score
11
I wrote a reply the other day....seems to have disappeared into the ether.

michael barry said:
Harold,

Armando thought much the same thing............................about sebum getting backed up there.

I am not that familiar with Armando's theories. I have seeen a bit of back and forth with Bryan about sebum but never really tried to follow.

NOTE------------Salycic acid is one hell of an anti-inflammatory. T-SAL has never been tested for Androgenic Alopecia though.................might be interesting to try.

I am beginning to think you might want something really rather strong - an immunosupressant rather than an anti-inflammatory even. If we are to think of Androgenetic Alopecia as being a type of "miniature organ rejection". Something like a topical corticosteroid would be perfect - if they werent antiproliferative to keratinocytes. :roll: The problem is even if it does work we dont know how hard you have to knock out the system and that makes me kind of nervous. If PGD2 is the culprit for instance is a topical COX inhibitor enough or is that not really making much difference?
Really need to see some sort of trial based on that last Cotsarelis patent to have a lot of confidence. And its nice to have as much confidence as possible that something is working when you are stepoping away from the established treatments.

SECOND NOTE: Ive suggested as much about DKK-1. DKK-1 kills keratinocyte cells, so you have dead keratinocyte cells flowing out of the body riding the hair up near an area with no immunological priveledges (the infidulum). The immune system might be attacking the dead cells there.

It would be interesting to see what an anti-DKK1 substance could do in Androgenetic Alopecia.

I suspect this is coming what wirth Folica and the general emphasis on wnt/beta-catenin in hair loss//growth.

Harold, as always, the lack of testing is infuriating. It would only take a couple of men and a doctor to try these things and see if there was any efficacy.

I have some sympathy here. Research is a slow process. Especially when "done right". and especially something like this where a simple trial has to be conducted for at least 3 to 6 months before we can see definite in vivo results.

However, head hair growth is slowed by androgens in test tubes also..................I keep that in mind.

Good point. Its funny how you can get so wrapped up in things that even something as simple as that is ignored. I wonder how much of the immmune response is wiped out with the ammount of material used in vivo. Can it be ruled out? Is PGD2 being produced?

Its definitley not the mites that live off sebum, because nioxin had a product that dealt with that and it wasn't successful.

This is the frustrating thing for me is that the success of antifungals seems to show that they might play a biggish role. Ketoconazole can be explained as an antiandrogen of sorts or a hyperrtrichotic but piroctine olamine is a unrelated antifungal. I would think the odds of it also being antiandrogenic would be low indeed and yet it seems to perform identically. Strange.
What was the nioxin product? I have never heard of this.
hh
 

michael barry

Senior Member
Reaction score
14
I would think the odds of it also being antiandrogenic would be low indeed and yet it seems to perform identically. Strange.
What was the nioxin product? I have never heard of this.


Piroctone Olamine was found to reduce sebum output also, just like Ketoconazole. They didn't give the percentages. Keto shampoo reduced sebaceous gland SIZE by something like 19% and sebum secretion also.


C. Piérard-Franchimont, V. Goffin, F. Henry, I. Uhoda, C. Braham, G. E. Piérard.

Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations.

International Journal of Cosmetic Science Volume 24, Issue 5, Page 249-256, Oct 2002

Synopsis

Hair shedding and hair thinning have been reported to be affected by dandruff and seborrhoeic dermatitis. The present study was conducted in 150 men presenting with telogen effluvium related to androgenic alopecia associated with dandruff. They were randomly allocated to three groups receiving each one of the three shampoos in the market containing either 1% ketoconazole (KTZ), 1% piroctone olamine (PTO) or 1% zinc pyrithione (ZPT). Shampoos had to be used 2-3 times a week for 6 months. Hair shedding during shampoo was evaluated semiquantitatively. Hair density on the vertex was evaluated on photographs using a Dermaphot. Trichograms were used for determining the anagen hair percentage and the mean proximal hair shaft diameter using computerized image analysis. The sebum excretion rate (SER, g cm2 h1) was also measured using a Sebumeter®.
The three treatments cleared pruritus and dandruff rapidly. At end point, hair density was unchanged, although hair shedding was decreased (KTZ: -17.3%, PTO: -16.5%, ZPT: -10.1%) and the anagen hair percentage was increased (KTZ: 4.9%, PTO: 7.9%, ZPT: 6.8%). The effect on the mean hair shaft diameter was contrasted between the three groups of volunteers (KTZ: 5.4%, PTO: 7.7%, ZPT: -2.2%). In conclusion, telogen effluvium was controlled by KTZ, PTO and ZPT shampoos at 1% concentration. In addition, KTZ and PTO increased the mean hair shaft thickness while discretely decreasing the sebum output at the skin surface.
From the full study:

Conclusion

The present study comparing 1% KTZ, 1% PTO and 1% ZPT shampoos has demonstrated that these products have some other benefits in addition to their reported antidandruff effect. The data show that these shampoos have a beneficial effect on the anagen/ telogen ratio, by increasing the anagen hair percentage in subjects with dandruff. This results in a reduced hair shedding. In addition, the data show that 1% KTZ and 1% PTO, but not 1% ZPT, produce a beneficial effect on scalp seborrhoea and hair shaft diameter. The reason for such opposite effect is unknown. Finally, the data show that scalp seborrhoea is inversely correlated with hair thickness. The virtue of such a finding is its simplicity. However, the results cannot be taken at face value. There may remain debate whether reducing sebum excess on the scalp may lead to thicker hair, and whether increasing scalp seborrhoea may be accompanied by a reduction in the hair shaft diameter



Topical Roxythromicyn has been in trials for hairloss. I think 8 out of 12 or something like that had better growth with it in vertex baldness, but its been a while. Roxythromicyn is a immunosuppressant...........................but topical cyclosporin has been tried and didnt work nearly as well as internal cyclosporin did. Immuno T-cells are made in other parts of the body and travel around looking for things that appear to be foreign to attack. Ah...................here is the page:


The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

This study is ongoing, but not recruiting participants.

Sponsored by: Hamamatsu University

Information provided by: Hamamatsu University
ClinicalTrials.gov Identifier: NCT00197379

Purpose
The purpose of this study is exploiting the new drugs for androgenetic alopecia because there are still no effective and safe topical drug for androgenetic alopecia. Roxithomycin is one of the macrolide antibiotics that has immunomodulatory effects. We firstly found that roxithromycin increases the rate of murine and human hair follicle elongation in vitro. Therefore, we apply this drug on this disease therapy.



Condition Intervention
Alopecia
Drug: roxithromycin



Genetics Home Reference related topics: Hair Diseases and Hair Loss

MedlinePlus related topics: Hair Diseases and Hair Loss

ChemIDplus related topics: Roxithromycin

U.S. FDA Resources

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Placebo Control, Crossover Assignment, Safety/Efficacy Study

Official Title: The Study for New Effect of Roxithromycin on Androgenetic Alopecia.


Further study details as provided by Hamamatsu University:


Secondary Outcome Measures:
Pathological study taken from lesional scalp skin. [ Time Frame: One year ]


Estimated Enrollment: 20
Study Start Date: May 2005
Estimated Study Completion Date: January 2007

Detailed Description:
The topical therapy for androgenetic alopecia is still not enough to improve cosmetically. Thereforem we try to find new effective and safe topical therapy for this disease. Roxithromycin has not only antibacterial action but also immunomodulatory and anti-inflamatory potency. For example, roxitromycin inhibits T cell responces to mitogens and production of cytokines, IL-2 and IL-5. We firstly found that roxitromycin increased human and murine hair elongation in vitro to inhibit apoptosis of hair bulb. Then, we wish to apply roxithromycin on the therapy for androgenetic alopecia.

Eligibility
Ages Eligible for Study: 20 Years and older
Genders Eligible for Study: Both
Accepts Healthy Volunteers: Yes

Criteria

Inclusion Criteria:

Androgenetic alopecia



I dont know how that turned out.............
 

michael barry

Senior Member
Reaction score
14
BTW---the nioxin product was called "semodex". It supposedly killed the eggs demodex mites layed in human sebum or whatever. It must not have worked.



I try to keep in mind that castration stops further balding and dutasteride sure seems to stop further balding. Ive seen so many pictures of females with lovely hair who decided to "become" men and take testosterone go Male Pattern Bald very quickly that I decided about 2-3 years ago that whatever happens is downstream of androgens and can be stopped by stopping androgens at the androgen receptor if possible. What precisely induces the immune response intrigues me because of what Kligman observed with vellus hairs from male pattern baldness subjects regrowing on immuno deficient mice, but as Bryan has pointed out....................we dont know the androgen levels in those mice and that experiment has never been duplicated. Im guessing the dead Keratinocyte cells near the infidulum are what are dying (hyperkeratinization is linked with other auto-immune disorders as well as overexpression of TGF-beta and excessive collagen distribution around the rejected organ----sound familiar?) and attracting a T-cell response and the ensuing inflammation. But who knows until we know............




ICX's phase two results are very evasive BTW.- It looks like they are stuck and are giving up unless someone buys what they have or is willing to pay them to do any more research. They will finish the last cohort over the summer, release their results in September. They provided no stat analysis, no pictures, nothing. They just claimed they grew more hair----------which doesn't mean sh*t to me.

Its Follica's wounding and Wnt7a protocol or nothing as far as "making" new hair at this point. Nothing is on the horizon that I know of.
 

harold

Established Member
Reaction score
11
michael barry said:
I would think the odds of it also being antiandrogenic would be low indeed and yet it seems to perform identically. Strange.
What was the nioxin product? I have never heard of this.


Piroctone Olamine was found to reduce sebum output also, just like Ketoconazole. They didn't give the percentages. Keto shampoo reduced sebaceous gland SIZE by something like 19% and sebum secretion also.


[quote:dsaas29j]C. Piérard-Franchimont, V. Goffin, F. Henry, I. Uhoda, C. Braham, G. E. Piérard.

Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations.
[/quote:dsaas29j]

I have this one. The sebum excretion rates were reduced by 4.8% and 2.9% in the keto and PO groups respectively. That figure of reducing sebaceous gland size - I think that comes from a study on oral ketoconazole intake. It didnt come from this study.

Topical Roxythromicyn has been in trials for hairloss. I think 8 out of 12 or something like that had better growth with it in vertex baldness, but its been a while. Roxythromicyn is a immunosuppressant...........................but topical cyclosporin has been tried and didnt work nearly as well as internal cyclosporin did. Immuno T-cells are made in other parts of the body and travel around looking for things that appear to be foreign to attack. Ah...................here is the page:


[quote:dsaas29j]The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

This study is ongoing, but not recruiting participants.

Sponsored by: Hamamatsu University

Information provided by: Hamamatsu University
ClinicalTrials.gov Identifier: NCT00197379

Purpose
The purpose of this study is exploiting the new drugs for androgenetic alopecia because there are still no effective and safe topical drug for androgenetic alopecia. Roxithomycin is one of the macrolide antibiotics that has immunomodulatory effects. We firstly found that roxithromycin increases the rate of murine and human hair follicle elongation in vitro. Therefore, we apply this drug on this disease therapy.



I dont know how that turned out.............[/quote:dsaas29j]

Interesting.
hh
 

treeshrew

Experienced Member
Reaction score
0
CONCLUSION: Comparative data suggest that there may be a significant action of KCZ upon the course of androgenic alopecia and that Malassezia spp. may play a role in the inflammatory reaction. The clinical significance of the results awaits further controlled study in a larger group of subjects.

Doesn't sound too conclusive to me.

If you don't have a pre-existing scalp condition I don't see why you'd use Nizoral. No shampoo should be grouped with treatments like finasteride and minoxidil.

It should be the "big 2".
 

bornthisway

Established Member
Reaction score
9
harold said:
michael barry said:
I would think the odds of it also being antiandrogenic would be low indeed and yet it seems to perform identically. Strange.
What was the nioxin product? I have never heard of this.


Piroctone Olamine was found to reduce sebum output also, just like Ketoconazole. They didn't give the percentages. Keto shampoo reduced sebaceous gland SIZE by something like 19% and sebum secretion also.


[quote:gv002vya]C. Piérard-Franchimont, V. Goffin, F. Henry, I. Uhoda, C. Braham, G. E. Piérard.

Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations.

I have this one. The sebum excretion rates were reduced by 4.8% and 2.9% in the keto and PO groups respectively. That figure of reducing sebaceous gland size - I think that comes from a study on oral ketoconazole intake. It didnt come from this study.

Topical Roxythromicyn has been in trials for hairloss. I think 8 out of 12 or something like that had better growth with it in vertex baldness, but its been a while. Roxythromicyn is a immunosuppressant...........................but topical cyclosporin has been tried and didnt work nearly as well as internal cyclosporin did. Immuno T-cells are made in other parts of the body and travel around looking for things that appear to be foreign to attack. Ah...................here is the page:


[quote:gv002vya]The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

This study is ongoing, but not recruiting participants.

Sponsored by: Hamamatsu University

Information provided by: Hamamatsu University
ClinicalTrials.gov Identifier: NCT00197379

Purpose
The purpose of this study is exploiting the new drugs for androgenetic alopecia because there are still no effective and safe topical drug for androgenetic alopecia. Roxithomycin is one of the macrolide antibiotics that has immunomodulatory effects. We firstly found that roxithromycin increases the rate of murine and human hair follicle elongation in vitro. Therefore, we apply this drug on this disease therapy.



I dont know how that turned out.............[/quote:gv002vya]

Interesting.
hh[/quote:gv002vya]

It seems lipoxidil offered Roxythromicyn via their website in 2006.. results seemed minimal, someone also emailed the study author and received no reply. I've emailed a high news coverage study author (different study) in the past and did get a reply in a day or so.

goata007:
the link says:

Study Start Date: May 2005
Estimated Study Completion Date: January 2007

I emailed the professor last year (I think around september) asking about the trial but didn't get a reply. Send him an email and you may get a reply

danboy:
I used the roxithromycin from Lipoxidil. Nothing. I think FrankBuzzin did too, he though maybe his hair got darker.

hairsite 4 month review:

4 month with Roxithromycin

First some background. I am a nw3 with low density and regression/thinning at the sides as well. I have been on finasteride/minoxidil well over a year (little or no regrowth, slowed down hairloss) before starting topical Roxithromycin.

I apply Topical Roxithromycin once a day at the hairline, sides and crown. The good news is that this 3 month supply will last me about twice that time, so it only costs me about 10 dollars a month. Unfortunately the cream is pretty much impossible to apply on areas with hair, I would rather have seen it in liquid form.

The results have been ok, but I think we should demand more from a new hairgrowth agent in 2006.

I have not seen any regrowth of terminal hairs at my hairline and not enough to see any difference in my crown area. But since I have no bald spot but only thinning it is hard to tell. Nothing spectacular at least.

I have seen some regrowth of terminal hairs at the sides though. Especially at my temples. It worked very fast in these areas, after one month I could see some darker hairs on my left temple and I have had vellus hair turn terminal ever since then. My right temple did not respond that good, but I could start seeing a difference at month two. minoxidil did not grow any hair in these areas.

Although I have grown visable, terminal hairs it is not enough to make that much of a cosmetical improvement. I believe my ?success? come from the fact that these areas had recently been thinning a lot (in the last 6 months) or that the sides are not that affected from DHT.

I have not read anyone else having any regrowth from rox so my conclusion is that it probably does not work that good in general. I am not sure that I will continue use rox after my bottle is empty, that depends on if I continue see any more regrowth.

Rox may have some potential but the solution from lipoxidil.com is not effective enough for me to recommend it. As I said earlier I would like to see a liquid formulation (a new ingredient in spectral dnc perhaps?) that the user could apply on the whole scalp, maybe then we could see at least some thickening of vellus hair. But dont expect anything for your hairline.

From lipoxidil website:

October,10th 2006 Our new MLL technology makes it possible. Lipoxidil announces a high dosage bald spot and receding hairline treatment. Minoxidil 20 S - a 20 % minoxidil lotion without alcohol to treat these stubborn areas previously not responding to conventional minoxidil. As bald spots are often associated with a deposit of so-called "collagen or connective tissue streamers" beneath the follicle and micro-inflammation additional products to treat these symptoms will follow. For now Roxithromycin and InFlamil should be used to eliminate inflammation before starting a Minoxidil-S treatment.

I thought this was interesting - found it as a post elsewhere.

"michael barry wrote:
Doctor,

If youve gotten a message from me earlier, disregard this one. I think I screwed up sending it.

I have a bottle of topical roxythromicyn from lipoxidil.com. Its for hair. I seen a post of yours that was very enthusiastic about the possibliities with roxythromicyn. Im assuming that a topical would have to counteract TGF-beta 1, TNF alpha, and PKC as well as keep the fibroblast from depostiting too much collagen and breaking up any fibrosis to be successful in your opinion.


Why do you feel roxythromicyn might work?


ON another note..........topcial amacha, topcial apple proanthocyanins, topical ginko biloba and aminexil should be able to fufill all the above criteria for fighting hairloss if the list from male pattern baldness-research.org was right. If one added vitamin C in the form of abscorbyl palimitate, they'd even have a stimulant in the mix. What do you think of that little reg?"

Doctor: "Okay, this is sort of the top of my head as I'm studying for boards right now, so you'll have to forgive my inability to site specific studies.

Roxithromycin inhibits TNF-alpha activity. TNF-alpha is a proinflammatory molecule, which should be highly useful to people with hair loss secondary to an inflammatory processes like alopecia areata and seborrheic dermatitis. As an internal, roxithromycin appears to be very dangerous and can lead to sepsis due to downregulation of the proinflammatory immune response.

However, there are few things that you should know about TNF-alpha. Although it is a proinflammatory cytokine, it is also an anti-fibrotic cytokine. TNF-alpha actually seems to reduce the expression of the TGF-beta receptor on target cells, which means it actually inhibits the formation of fibrosis. Not only does it due that, but by downregulating the TGF-beta receptor it also inhibits TGF-beta induced apoptosis and inhibits the anti-protease activity that TGF-beta seems to have.

So, in a normal person with no male pattern baldness injury to the scalp will cause an increase in TNF-alpha promoting inflammation until TGF-beta is upregulated enough to overcome the inhibitory effects of TNF-alpha. TGF-beta can then proceed to put the hair into a state of dormancy while it also remodels the extracellular matrix through the use of fibroblasts. Normally, TGF-beta should stop doing it's job and then proteases should be activated again to remove the fibrosis and return the dermis to its normal configuration.

In male pattern baldness, the bolded part doesn't happen and the hair enters permanent dormancy while fibrosis continues to happen.

So, what you need to do if you're going to use this antibiotic topically is make sure that you're using something else topically or internally that would be a good TGF-beta inhibitor. Stopping one process and allowing the other won't cut it on this one. However, if your hair loss is strictly related to inflammation, you'll be in the clear.

Something else that you should know is that pretty much all the drugs that have been developed for Alopecia Areata using TNF-alpha inhibition as the goal have not shown good results from what I've heard.

As for your topical...that looks pretty good to me.

In reality, baldness is simply the upregulation of a process that is normal for the human body. Somehow, an abnormal androgen receptor has caused androgen production and binding of the androgen receptor to be linked to a fibrotic response. We'll just have to see what science tells us in the next few years.

I'm actually starting to wonder if male pattern baldness is not only related to androgens, but also to a possible TNF-alpha deficiency or an alpha2-macroglobulin deficiency (which would normally inactivate surplus TGF-beta."

'Me again.........Doctor seems to be a big believer that if we could just inhibit TGF beta in the scalp, TNF alpha and Protien Kinease C in the scalp............eliminate inflammation and fibrosis.............we'd be in the clear with no need for hormonal interventions (dutasteride, finasteride, spironolactone, or phytoestrogens).

Boiled beer and apple cider vinegar along with topical curcumin mixed in the brew should fufill alot of that above very cheaply. Ive wondered what someone could do to decrease collagen deposition in targeted areas (scalp). The ACV is a potent anti-inflammatory by the way. From my understanding fibrosis occurs after periods of chronic inflammation anyway. Im sensitive to the fact that many others have very negative experiences with finasteride.'
 
Top